Marimed Inc.
- MRMD · OTC
- Medicinal Chemicals & Botanical Products
- Norwood, MA
- 923 employees
- CIK 0001522767
Updated from SEC filings through
Top things to know
Executives
- Jon R. Levine President and CEO 4, 2026-07-17
- Mario Pinho Chief Financial Officer 4, 2026-07-17
- Ryan Crandall Chief Commercial Officer 4, 2026-09-28
- Timothy Shaw Chief Operating Officer 4, 2026-09-01
What leadership is saying
“The second quarter represented meaningful progress for MariMed. Revenue increased in both our wholesale and retail businesses sequentially and year over year, resulting in the highest quarterly revenue in our history. These results also reflect a substantial increase in sequential adjusted EBITDA and another quarter in which we generated positive cash flow from operations”
Earnings press release (8-K Ex. 99.1), filed August 12, 2026
Marimed Inc. is a U.S. public company in medicinal chemicals & botanical products (SIC 2833), headquartered in Norwood, MA. It trades as MRMD on OTC. Revenue was $160M in the fiscal year ending December 31, 2025, +1.3% from the year before. It reported about 923 employees. Jon R. Levine is President and CEO.
Five-year financials
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $160M 10-K, 2026-03-12 | $158M 10-K, 2026-03-12 | $149M 10-K, 2025-03-06 | $134M 10-K, 2024-03-07 | $121M 10-K, 2023-03-03 |
| Operating income | -$2.8M 10-K, 2026-03-12 | $2.6M 10-K, 2026-03-12 | $14.4M 10-K, 2025-03-06 | $20.4M 10-K, 2024-03-07 | $26.9M 10-K, 2023-03-03 |
| SG&A | $26.1M 10-K, 2026-03-12 | $25.6M 10-K, 2026-03-12 | $22.1M 10-K, 2025-03-06 | $20.7M 10-K, 2024-03-07 | $27.6M 10-K, 2023-03-03 |
| Net income | -$14.5M 10-K, 2026-03-12 | -$12.5M 10-K, 2026-03-12 | -$16.0M 10-K, 2025-03-06 | $13.5M 10-K, 2024-03-07 | $7.2M 10-K, 2023-03-03 |
Annual figures from XBRL in each company's own filings. Click a figure to open the filing. SG&A marked derived is general and administrative plus selling and marketing.
Leadership and board
| Name | Title | Source |
|---|---|---|
| Jon R. Levine MariMed Inc | President and CEO | 4, 2026-07-17 |
| Mario Pinho | Chief Financial Officer | 4, 2026-07-17 |
| Ryan Crandall Chief Commercial Officer at MariMed, Inc. | Chief Commercial Officer | 4, 2026-09-28 |
| Timothy Shaw | Chief Operating Officer | 4, 2026-09-01 |
What Marimed Inc. does
We are a multi-state cannabis operator (“MSO”) in the United States, headquartered in Norwood, Massachusetts, dedicated to improving lives every day through our high-quality products, our actions, and our values. We develop, own, and manage seed to sale state-licensed, state-of-the-art, regulatory-compliant facilities for the cultivation, production, and dispensing of medicinal and adult-use cannabis. We have created and continue to develop our own brands of premium cannabis flower, concentrates, edibles, and other precision-dosed products utilizing our proprietary strains and formulations.
Item 1. Business, 10-K for the year ending December 31, 2025
Shares and governance
| Shares outstanding | 403.0 million (as of August 10, 2026) | 10-Q, August 13, 2026 |
|---|---|---|
| Public float | $22.6M (as of June 30, 2025) | 10-K, March 12, 2026 |
| Reportable segments | 1 (period ending June 30, 2026) | 10-Q, August 13, 2026 |
| Latest proxy statement | Meeting October 28, 2026 (filed September 22, 2026) | DEF 14A, September 22, 2026 |
| Auditor | M&k Cpas, PLLC (The Woodlands, TX) | Latest 10-K |
Insider trades
Open-market buys and sales by officers and directors, from Forms 4 and 5. One row per filing.
| Date | Insider | Trade | Shares | Value | Source |
|---|---|---|---|---|---|
| May 22, 2026 | Jon R. Levine President and CEO | Buy | 60,000 | $5K | Form 4, May 26, 2026 |
| May 20, 2026 | Jon R. Levine President and CEO | Buy | 40,000 | $3K | Form 4, May 20, 2026 |
| December 12, 2025 | Timothy Shaw Chief Operating Officer | Buy | 45,455 | $5K | Form 4, December 16, 2025 |
Recent 8-K events
- 8-K filed 2026-10-29
- Item 5.07 Submission of matters to a vote of security holders
- Item 8.01 Other events
- 8-K filed 2026-09-23
- Item 8.01 Other events
- 8-K filed 2026-08-12
- Item 2.02 Results of operations and financial condition (earnings release)
- 8-K filed 2026-06-08
- Item 5.07 Submission of matters to a vote of security holders
- 8-K filed 2026-05-13
- Item 2.02 Results of operations and financial condition (earnings release)
- 8-K filed 2026-03-11
- Item 2.02 Results of operations and financial condition (earnings release)
- 8-K filed 2026-03-02
- Item 1.01 Entry into a material definitive agreement
- Item 2.03 Creation of a direct financial obligation
- Item 3.02 Unregistered sales of equity securities
- Item 5.03 Amendments to articles or bylaws; change in fiscal year
- 8-K filed 2025-11-05
- Item 2.02 Results of operations and financial condition (earnings release)
- 8-K filed 2025-08-06
- Item 2.02 Results of operations and financial condition (earnings release)
- 8-K filed 2025-06-13
- Item 5.07 Submission of matters to a vote of security holders
Frequently asked questions about Marimed Inc.
- What does Marimed Inc. do?
- In its own words, from Item 1 of its 10-K: "We are a multi-state cannabis operator (“MSO”) in the United States, headquartered in Norwood, Massachusetts, dedicated to improving lives every day through our high-quality products, our actions, and our values. We develop, own, and manage seed to sale state-licensed, state-of-the-art, regulatory-compliant facilities for the cultivation, production, and dispensing of medicinal and adult-use cannabis. We have created and continue to develop our own brands of premium cannabis flower, concentrates, edibles, and other precision-dosed products utilizing our proprietary strains and formulations."
- What is Marimed Inc.'s revenue?
- $160M for the fiscal year ending December 31, 2025, from its 10-K filed March 12, 2026.
- Is Marimed Inc. profitable?
- Marimed Inc. reported net income of -$14.5M for the fiscal year ending December 31, 2025.
- How many employees does Marimed Inc. have?
- About 923 as of December 31, 2025, as stated in its annual report.
- Who is the CEO of Marimed Inc.?
- Jon R. Levine, President and CEO, as named in a 4 filed July 17, 2026.
- Who is the CFO of Marimed Inc.?
- Mario Pinho, Chief Financial Officer, as named in a 4 filed July 17, 2026.
- Where is Marimed Inc. headquartered?
- Norwood, MA.
- What is Marimed Inc.'s stock ticker?
- MRMD on OTC.
- What industry is Marimed Inc. in?
- Medicinal Chemicals & Botanical Products, SIC code 2833.
- What is Marimed Inc.'s website?
- marimedinc.com. Investor relations: https://ir.marimedinc.com.
- When does Marimed Inc. report earnings next?
- November 12, 2026 at 08:00. Source: ir_events.
- Is Marimed Inc. a public company?
- Yes. Marimed Inc. files with the SEC under CIK 0001522767 and trades as MRMD.
- Who audits Marimed Inc.?
- M&k Cpas, PLLC, The Woodlands, TX, as named in its latest annual report (10-K).
- How many shares of Marimed Inc. are outstanding?
- 403.0 million shares as of August 10, 2026, from its 10-Q filed August 13, 2026.
- What is Marimed Inc.'s public float?
- $22.6M as of June 30, 2025, as reported on the cover of its 10-K filed March 12, 2026.
- How many business segments does Marimed Inc. report?
- 1 reportable segment for the period ending June 30, 2026, from its 10-Q filed August 13, 2026.
- When is Marimed Inc.'s annual shareholder meeting?
- October 28, 2026, per its proxy statement (DEF 14A) filed September 22, 2026.
- Have Marimed Inc. insiders traded stock recently?
- Since December 12, 2025, officers and directors reported 0 open-market sales and 3 purchases worth about $13K on Forms 4 and 5. The most recent: Jon R. Levine (President and CEO) bought 60,000 shares on May 22, 2026.